Attached files
| file | filename |
|---|---|
| 8-K - 8-K Q2'18 PRESS RELEASE - CYPRESS SEMICONDUCTOR CORP /DE/ | q218pressrelease8-k.htm |
EXHIBIT 99.1
Contacts:
Thad Trent
EVP Finance & Administration and CFO
(408) 943-2925
Ann Minooka
Vice President, Corporate Communications
(408) 456-1962
For Immediate Release
Cypress Reports Second Quarter 2018 Results
SAN JOSE, Calif., July 26, 2018—Cypress Semiconductor Corporation (NASDAQ: CY), a leader in embedded solutions, today announced its second quarter 2018 results with the following highlights:
• | Record revenue of $624.1 million, a 7.2% increase sequentially |
• | GAAP and non-GAAP gross margins were 37.5% and 46.3%, respectively, and represent a 500 bps and 540 bps increase year over year |
• | GAAP and non-GAAP diluted EPS were 7 and 33 cents respectively |
• | MCD revenue increased 9.4% sequentially driven by strength in microcontrollers and wireless connectivity |
“The team is executing well and has delivered record revenue this quarter as Cypress continues to gain share in our high-growth markets of Automotive, Industrial and Consumer,” said Hassane El-Khoury, Cypress’ president and chief executive officer. “Our platform of Connect, Compute and Store solutions gives developers everything they need to create winning IoT products quickly and easily.”
Revenue and earnings for the quarter are shown below with comparable periods:
(In thousands, except per-share data)
GAAP1 | NON-GAAP2 | |||||||||||||||||||||||
Q2 2018 | Q1 2018 | Q2 2017 | Q2 2018 | Q1 2018 | Q2 2017 | |||||||||||||||||||
Revenue | $ | 624,090 | $ | 582,241 | $ | 593,776 | $ | 624,090 | $ | 582,241 | $ | 593,776 | ||||||||||||
Gross margin | 37.5 | % | 36.5 | % | 32.5 | % | 46.3 | % | 45.9 | % | 40.9 | % | ||||||||||||
Operating margin | 8.1 | % | 6.1 | % | 1.5 | % | 22.3 | % | 19.5 | % | 15.4 | % | ||||||||||||
Net income (loss) | $ | 27,706 | $ | 9,078 | $ | (16,920 | ) | $ | 124,964 | $ | 100,296 | $ | 74,704 | |||||||||||
Diluted EPS (loss) | $ | 0.07 | $ | 0.02 | $ | (0.05 | ) | $ | 0.33 | $ | 0.27 | $ | 0.21 | |||||||||||
Revenue and earnings are shown below:
(In thousands, except per-share data)
GAAP1 | NON-GAAP2 | |||||||||||||||
Six Months | Six Months | |||||||||||||||
Q2 2018 | Q2 2017 | Q2 2018 | Q2 2017 | |||||||||||||
Revenue | $ | 1,206,331 | $ | 1,125,650 | $ | 1,206,331 | $ | 1,125,650 | ||||||||
Gross margin | 37.0 | % | 31.1 | % | 46.1 | % | 40.1 | % | ||||||||
Operating margin | 7.2 | % | (0.4 | )% | 21.0 | % | 13.9 | % | ||||||||
Net income (loss) | $ | 36,784 | $ | (59,919 | ) | $ | 225,260 | $ | 120,591 | |||||||
Diluted EPS (loss) | $ | 0.10 | $ | (0.18 | ) | $ | 0.60 | $ | 0.33 | |||||||
1. In 2018, certain expenses have been reclassified as part of cost of revenue. Historical results have been conformed with the 2018 presentation.
2. See the “Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures” tables (“Non-GAAP Reconciliation Tables”) included below.
BUSINESS REVIEW
+ Cypress announced key developments in its wireless connectivity solutions for the automotive and industrial markets during the quarter. Pioneer selected Cypress’ automotive-grade Wi-Fi® and Bluetooth® combo solution for its flagship in-dash infotainment receiver. The solution uses Cypress’ Real Simultaneous Dual Band (RSDB) technology to enable passengers to display and use their smartphone’s apps via Apple CarPlay™ or Android Auto™. Additionally, Cypress collaborated with Semtech on a two-chip LoRaWAN™-based module for smart city applications that uses Cypress’ PSoC® 6 microcontroller (MCU) with integrated Bluetooth Low Energy (BLE) and hardware-based security to deliver highly protected device-to-cloud connectivity.
+ Cypress continued to expand its high-performance, differentiated fail-safe storage offerings with the new Semper™ NOR Flash family - the world’s most advanced Flash solution for mission-critical automotive and industrial applications. The family has already won multiple major automotive platforms for next-generation instrument clusters and Advanced Driver Assistance Systems (ADAS).
+ Cypress also announced multiple key developments for its industry-leading USB-C solutions. The company’s EZ-PD™ USB-C controllers with Power Delivery (PD) have been selected for key reference designs for PCs and peripherals, with one qualified by Intel for use in Thunderbolt™ 3 host and peripheral
designs, and one qualified by AMD for use with its “Raven Ridge” processors for notebook and desktop PCs. Cypress also continued to expand its portfolio with the industry’s first 7-port USB-C hub controller for notebook and tablet docking stations and monitor docks.
+ On July 19, 2018, Cypress paid a cash dividend of $39.4 million, or $0.11 per share, to holders of record of the Company’s common stock as of the close of business on June 28, 2018. The dividend was equivalent to a 2.8% annualized yield as of June 29, 2018.
REVENUE SUMMARY
(In thousands, except percentages)
(Unaudited)
Three Months Ended | |||||||||||||||||
July 1, 2018 | April 1, 2018 | July 2, 2017 | Sequential Change | Year-over-year Change | |||||||||||||
Business Unit | |||||||||||||||||
MCD | $ | 368,526 | $ | 336,710 | $ | 360,533 | 9.4 | % | 2.2 | % | |||||||
MPD | $ | 255,564 | $ | 245,531 | $ | 233,243 | 4.1 | % | 9.6 | % | |||||||
Total | $ | 624,090 | $ | 582,241 | $ | 593,776 | 7.2 | % | 5.1 | % | |||||||
Three Months Ended | ||||||||
July 1, 2018 | April 1, 2018 | July 2, 2017 | ||||||
End Market | ||||||||
Industrial | 19.0 | % | 17.9 | % | 19.2 | % | ||
Automotive | 30.8 | % | 34.3 | % | 30.8 | % | ||
Consumer | 31.3 | % | 31.3 | % | 34.1 | % | ||
Enterprise | 18.9 | % | 16.5 | % | 15.9 | % | ||
Total | 100 | % | 100 | % | 100 | % | ||
1. | The Microcontroller and Connectivity Division ("MCD") includes microcontroller, wireless connectivity and USB products and the Memory Products Division ("MPD") includes RAM, Flash and AgigA Tech products. |
THIRD QUARTER 2018 FINANCIAL OUTLOOK
For the third quarter of 2018, Cypress estimates financial results as follows:
GAAP | Non-GAAP | |
Revenue | $655 million to $685 million | |
Gross Margin | 38.0% - 39.0% | 46.5% - 47.5% |
Diluted EPS | $0.11 to $0.15 | $0.36 to $0.40 |
A reconciliation of GAAP forward-looking estimates to non-GAAP forward-looking estimates may be found in the Non-GAAP Reconciliation Tables at the end of this earnings report.
The timing and amount of certain material items, including restructuring charges, asset impairments, changes in value of deferred compensation assets and liabilities, impact of stock-based compensation from modification of equity awards, and the tax impact of non-GAAP adjustments, which are needed to estimate GAAP financial measures, are either inherently unpredictable or outside the control of the Company, and may have a significant impact on the Company’s financial results.
CONFERENCE CALL AND WEBCAST INFORMATION
Cypress will host its quarterly conference call on July 26, 2018 at 1:30 p.m. Pacific Daylight Time to discuss its second quarter 2018 results and outlook for the third quarter of 2018.
All interested parties may dial 517-308-9119 and provide the passcode “Cypress” to listen to the call. The event will be broadcast over the Internet and may be accessed through Cypress’ website at www.cypress.com/investors. The archived presentation will be available for at least two weeks immediately following the event.
FOLLOW CYPRESS ONLINE
Join the Cypress Developer Community 3.0, read our blog, follow us on Twitter, Facebook and LinkedIn, and watch Cypress videos on our Video Library or YouTube.
ABOUT CYPRESS
Cypress is a leader in advanced embedded solutions for the world’s most innovative automotive, industrial, smart home appliances, consumer electronics and medical products. Cypress’ microcontrollers, analog ICs, wireless and USB-based connectivity solutions and reliable, high-performance memories help engineers design differentiated products and get them to market first. Cypress is committed to providing customers with the best support and development resources on the planet enabling them to disrupt markets by creating new product categories. To learn more, go to www.cypress.com.
NON-GAAP FINANCIAL MEASURES
To supplement its condensed consolidated unaudited financial results presented in accordance with GAAP, Cypress uses the non-GAAP financial measures listed below, which are adjusted from the most directly comparable GAAP financial measures to exclude certain items, as described in more detail below.
• | Non-GAAP gross profit; |
• | Non-GAAP gross margin; |
• | Non-GAAP cost of revenues; |
• | Non-GAAP interest and other expense, net; |
• | Non-GAAP research and development expenses; |
• | Non-GAAP selling, general and administrative expenses; |
• | Adjusted EBITDA; |
• | Non-GAAP income tax provision (benefit); |
• | Non-GAAP pre-tax profit; |
• | Non-GAAP pre-tax profit margin; |
• | Non-GAAP operating income (loss); |
• | Non-GAAP operating margin; |
• | Non-GAAP net income (loss); and |
• | Non-GAAP diluted earnings (loss) per share. |
Management believes that these non-GAAP financial measures reflect an additional and useful way of viewing aspects of the Company's operations which, when viewed in conjunction with Cypress' GAAP results, provide a more comprehensive understanding of the various factors and trends affecting the Company's business and operations.
The Company presents non-GAAP financial measures because management uses these measures to analyze and assess the Company's financial results and to manage the business.
There are limitations in using non-GAAP financial measures including those discussed below. Moreover, the Company’s non-GAAP measures may be calculated differently than the non-GAAP financial measures used by other companies. The presentation of non-GAAP financial information is not meant to be considered in isolation or as a substitute for the most directly comparable GAAP financial measures. The non-GAAP financial measures supplement and should be viewed in conjunction with GAAP financial measures.
As presented in the Non-GAAP Reconciliation Tables in this press release, each of the non-GAAP financial measures excludes one or more of the following items:
Acquisition-related charges: Acquisition-related charges are not factored into management's evaluation of Cypress' long-term performance after the completion of acquisitions. However, a limitation of non-GAAP measures that exclude acquisition-related charges is that these charges may represent payments that reduce the cash available to the Company for other purposes. Acquisition-related expenses primarily include:
• | Amortization of purchased intangibles, including purchased technology, patents, customer relationships, trademarks, backlog and non-compete agreements; |
• | Amortization of step-up in value of inventory recorded as part of purchase price accounting; and |
• | One-time charges associated with the completion of an acquisition including items such as contract termination costs, severance and other acquisition-related restructuring costs; costs incurred in connection with integration activities; and legal and accounting costs. |
Stock-based compensation expense: Stock-based compensation expense relates primarily to employee stock options, restricted stock units, performance stock units and the employee stock purchase plan. Stock-based compensation expense is a non-cash expense that is affected by changes in market factors including the price of Cypress’ common shares, which are not within the control of management. In addition, the valuation of stock-based compensation is subjective, and the expense recognized by Cypress may be significantly different than the expense recognized by other companies for similar equity awards, which makes it difficult to assess Cypress’ results compared to its competitors. Accordingly, management excludes this item from its internal operating forecasts and models. However, a limitation of non-GAAP measures that exclude stock-based compensation expense is that they do not reflect the full costs of compensating employees.
Other adjustments: Additional items are excluded from non-GAAP financial measures because management does not consider them to be related to the core operating activities and ongoing operating performance of Cypress. Excluding these items, which can vary significantly from quarter to quarter, allows management to better compare Cypress’ period-over-period performance. However, limitations of non-GAAP measures that exclude these items include that these adjustments are often subjective and such non-GAAP measures may
not be comparable to similarly titled non-GAAP financial measures used by other companies. These adjustments primarily include:
• | Revenue from an intellectual property license; |
• | Changes in value of deferred compensation plan assets and liabilities; |
• | Investment-related gains or losses, including equity method investments; |
• | Restructuring and related costs; |
• | Debt issuance costs, including imputed interest related to the equity component of convertible debt; |
• | Asset impairments; |
• | Tax effects of non-GAAP adjustments; |
• | Certain other expenses and benefits; and |
• | Diluted weighted average shares non-GAAP adjustment - for purposes of calculating non-GAAP diluted earnings per share, the GAAP diluted weighted average shares outstanding is adjusted to exclude the benefits related to stock-based compensation expense, and include the impact of the capped call options related to the outstanding convertible notes. |
Adjusted EBITDA: Adjusted EBITDA is calculated by adjusting net income (loss) attributable to Cypress to exclude (without duplication): interest expense, income tax provision, depreciation, amortization, equity in net loss of equity method investees, and the non-GAAP adjustments described above (acquisition related charges, stock-based compensation expense, and other adjustments). Commencing in the second quarter of 2018, Cypress reconciles adjusted EBITDA to GAAP net income rather than operating income; prior period reconciliation tables have been revised to conform to the current presentation. Adjusted EBITDA may be useful to management, investors and other users of our financial information because the exclusion of certain gains, losses, and expenses facilitates comparisons of Cypress' operating performance on a period to period basis. Adjusted EBITDA should not be considered as a measure of discretionary cash available to invest in the growth of the business. In addition, adjusted EBITDA should not be considered as a substitute for, or superior to net income attributable to Cypress, operating income, or diluted earnings per share, or other financial measures prepared in accordance with GAAP.
FORWARD-LOOKING STATEMENTS
Statements in this press release that are not historical facts and that refer to Cypress or its subsidiaries’ plans and expectations for the future are forward-looking statements as such term is used in the Private Securities Litigation Reform Act of 1995. We may use words such as “may,” "will," “should,” “plan,” “anticipate,” “believe,” “expect,” “future,” “intend,” “estimate,” “predict,” “potential,” “continue” or similar expressions identify forward-looking statements. This press release includes, among others, forward-looking statements regarding our third quarter financial outlook (as well as the related GAAP to non-GAAP reconciling items). Our forward-looking statements are based on the expectations, beliefs, and intentions of, and the information available to, our executive management on the date of this press release. Forward-looking statements involve risks and uncertainties, and readers are cautioned not to place undue reliance on forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: potential tariffs and other disruptions in the international trade and investment environment; global economic and market conditions; our ability to execute on our Cypress 3.0 strategy and our margin improvement plan; risks related to paying down our indebtedness and meeting the covenants in our debt agreements; our efforts to retain and expand our customer base; business conditions and growth trends in the semiconductor market; competition; volatility in supply and demand for our products, including but not limited to the impact of seasonality on supply and demand; our ability to develop, introduce and sell new products and technologies; potential problems relating to our manufacturing activities; reliance on distributers, resellers, third-party manufacturers, and others; risks related to our “take or pay” agreements with certain vendors; the risk of defects, errors, or security vulnerabilities in our products; the impact of acquisitions; our ability to attract and retain key personnel; the unpredictability and expense of legal proceedings; and other risks and uncertainties described in the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," and “Quantitative and Qualitative Disclosures about Market Risk” sections in our most recent Annual Report on Form 10-K and in our subsequent quarterly filings with the Securities and Exchange Commission which are available on our investor relations website at http://investors.cypress.com/financial-information/sec-filings. We assume no responsibility to update our forward-looking statements.
Cypress, the Cypress logo and PSoC are registered trademarks and Semper and EZ-PD are trademarks of Cypress Semiconductor Corporation. All other trademarks are property of their owners.
CYPRESS SEMICONDUCTOR CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
July 1, 2018 | December 31, 2017 | |||||||
ASSETS | ||||||||
Cash, cash equivalents and short-term investments | $ | 112,718 | $ | 151,596 | ||||
Accounts receivable, net | 404,524 | 295,991 | ||||||
Inventories | 286,761 | 272,127 | ||||||
Property, plant and equipment, net | 291,026 | 289,554 | ||||||
Goodwill and other intangible assets, net | 2,046,609 | 2,154,592 | ||||||
Other assets | 362,859 | 373,190 | ||||||
Total assets | $ | 3,504,497 | $ | 3,537,050 | ||||
LIABILITIES AND EQUITY | ||||||||
Accounts payable | $ | 225,619 | $ | 213,101 | ||||
Income tax liabilities | 55,729 | 52,006 | ||||||
Revenue reserves, deferred margin and other liabilities | 480,436 | 497,838 | ||||||
Revolving credit facility and long-term debt | 883,741 | 956,513 | ||||||
Total liabilities | 1,645,525 | 1,719,458 | ||||||
Total Cypress stockholders' equity | 1,857,816 | 1,816,536 | ||||||
Non-controlling interest | 1,156 | 1,056 | ||||||
Total equity | 1,858,972 | 1,817,592 | ||||||
Total liabilities and equity | $ | 3,504,497 | $ | 3,537,050 | ||||
CYPRESS SEMICONDUCTOR CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
ON A GAAP BASIS
(In thousands, except per-share data)
(Unaudited)
Three Months Ended | Six Months Ended | ||||||||||||||||||
July 1, 2018 | April 1, 2018 | July 2, 2017 | July 1, 2018 | July 2, 2017 | |||||||||||||||
Revenues | $ | 624,090 | $ | 582,241 | $ | 593,776 | $ | 1,206,331 | $ | 1,125,650 | |||||||||
Cost of revenue1 | 389,952 | 369,849 | 401,031 | 759,801 | 775,797 | ||||||||||||||
Gross profit | 234,138 | 212,392 | 192,745 | 446,530 | 349,853 | ||||||||||||||
Research and development1 | 96,693 | 93,233 | 88,595 | 189,926 | 177,943 | ||||||||||||||
Selling, general and administrative1 | 86,599 | 83,397 | 95,258 | 169,996 | 176,591 | ||||||||||||||
Total operating expenses | 183,292 | 176,630 | 183,853 | 359,922 | 354,534 | ||||||||||||||
Operating income (loss) | 50,846 | 35,762 | 8,892 | 86,608 | (4,681 | ) | |||||||||||||
Interest and other expense, net | (14,143 | ) | (18,154 | ) | (16,407 | ) | (32,297 | ) | (35,766 | ) | |||||||||
Income (loss) before income taxes and non-controlling interest | 36,703 | 17,608 | (7,515 | ) | 54,311 | (40,447 | ) | ||||||||||||
Income tax provision | (5,154 | ) | (5,057 | ) | (4,504 | ) | (10,211 | ) | (9,431 | ) | |||||||||
Equity in net loss of equity method investees | (3,755 | ) | (3,461 | ) | (4,835 | ) | (7,216 | ) | (9,911 | ) | |||||||||
Net income (loss) | 27,794 | 9,090 | (16,854 | ) | 36,884 | (59,789 | ) | ||||||||||||
Net gain attributable to non-controlling interests | (88 | ) | (12 | ) | (66 | ) | (100 | ) | (130 | ) | |||||||||
Net income (loss) attributable to Cypress | $ | 27,706 | $ | 9,078 | $ | (16,920 | ) | $ | 36,784 | $ | (59,919 | ) | |||||||
Net income (loss) per share attributable to Cypress: | |||||||||||||||||||
Basic | $ | 0.08 | $ | 0.03 | $ | (0.05 | ) | $ | 0.10 | $ | (0.18 | ) | |||||||
Diluted | $ | 0.07 | $ | 0.02 | $ | (0.05 | ) | $ | 0.10 | $ | (0.18 | ) | |||||||
Cash dividend declared per share | $ | 0.11 | $ | 0.11 | $ | 0.11 | $ | 0.22 | $ | 0.22 | |||||||||
Shares used in net income (loss) per share calculation: | |||||||||||||||||||
Basic | 358,577 | 355,461 | 329,860 | 356,123 | 328,320 | ||||||||||||||
Diluted | 371,967 | 370,592 | 329,860 | 370,402 | 328,320 | ||||||||||||||
1. In 2018, certain expenses have been reclassified as part of cost of revenue and operating expenses. Historical results have been conformed with the 2018 presentation.
CYPRESS SEMICONDUCTOR CORPORATION
RECONCILIATION OF GAAP FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES
(In thousands, except per-share data)
(Unaudited)
Table A: GAAP to non-GAAP reconciling items: Three Months Ended Q2 2018 | ||||||||||||||||||||
Cost of revenues | Research and development | Selling, general and administrative | Interest and other expense, net | Income tax (provision) benefit | ||||||||||||||||
GAAP [i] | $ | 389,952 | $ | 96,693 | $ | 86,599 | $ | (17,898 | ) | $ | (5,154 | ) | ||||||||
[1] Stock-based compensation | 3,986 | 13,800 | 16,121 | — | — | |||||||||||||||
[2] Changes in value of deferred compensation plan | 102 | 467 | 572 | (1,123 | ) | — | ||||||||||||||
[3] Equity in net loss of equity method investees | — | — | — | 3,755 | — | |||||||||||||||
[4] Imputed interest on convertible debt, equity component amortization on convertible debt and others | — | — | — | 4,415 | — | |||||||||||||||
[5] Amortization of acquisition-related intangible assets and other | 49,438 | — | 4,355 | — | — | |||||||||||||||
[6] Gain on sale of cost method investment | — | — | (1,521 | ) | — | — | ||||||||||||||
[7] Restructuring charges | 1,589 | 33 | (383 | ) | — | — | ||||||||||||||
[8] Tax impact of non-GAAP adjustments | — | — | — | (377 | ) | 2,029 | ||||||||||||||
Non - GAAP [ii] | $ | 334,837 | $ | 82,393 | $ | 67,455 | $ | (11,228 | ) | $ | (3,125 | ) | ||||||||
Impact of reconciling items [ii - i] | $ | (55,115 | ) | $ | (14,300 | ) | $ | (19,144 | ) | $ | 6,670 | $ | 2,029 | |||||||
Table B: GAAP to non-GAAP reconciling items: Three Months Ended Q1 2018 | ||||||||||||||||||||
Cost of revenues | Research and development | Selling, general and administrative | Interest and other expense, net | Income tax (provision) benefit | ||||||||||||||||
GAAP [i] | $ | 369,849 | $ | 93,233 | $ | 83,397 | $ | (21,615 | ) | $ | (5,057 | ) | ||||||||
[1] Stock-based compensation | 3,584 | 6,713 | 8,161 | — | — | |||||||||||||||
[2] Changes in value of deferred compensation plan | 61 | 272 | 350 | (266 | ) | — | ||||||||||||||
[3] Equity in net loss and impairment of equity method investees | — | — | — | 3,461 | — | |||||||||||||||
[4] Imputed interest on convertible debt, equity component amortization on convertible debt and others | — | — | — | 3,431 | — | |||||||||||||||
[5] Loss on extinguishment of Spansion convertible notes | — | — | 3,258 | — | ||||||||||||||||
[6] Amortization of debt issuance costs | — | — | — | 1,073 | — | |||||||||||||||
[7] Amortization of acquisition-related intangible assets | 49,438 | — | 5,150 | — | — | |||||||||||||||
[8] Restructuring charges | 1,887 | 292 | 1,917 | — | — | |||||||||||||||
[9] Tax impact of non-GAAP adjustments | — | — | — | 393 | 2,043 | |||||||||||||||
Non - GAAP [ii] | $ | 314,879 | $ | 85,956 | $ | 67,819 | $ | (10,265 | ) | $ | (3,014 | ) | ||||||||
Impact of reconciling items [ii - i] | $ | (54,970 | ) | $ | (7,277 | ) | $ | (15,578 | ) | $ | 11,350 | $ | 2,043 | |||||||
Table C: GAAP to Non-GAAP reconciling items: Three Months Ended Q2 2017 | ||||||||||||||||||||
Cost of revenues | Research and development | Selling, general and administrative | Interest and other expense, net | Income tax (provision) benefit | ||||||||||||||||
GAAP [i] | $ | 401,031 | $ | 88,595 | $ | 95,258 | $ | (21,242 | ) | $ | (4,504 | ) | ||||||||
[1] Stock based compensation | 4,000 | 9,776 | 10,574 | — | — | |||||||||||||||
[2] Changes in value of deferred compensation plan | 137 | 563 | 896 | (1,584 | ) | — | ||||||||||||||
[3] Merger, integration, related costs and adjustments related to assets held for sale | 1,336 | (96 | ) | 1,193 | — | — | ||||||||||||||
[4] Inventory step-up related to acquisition accounting | 167 | — | — | — | — | |||||||||||||||
[5] Equity in net loss and impairment of equity method investees | — | — | — | 4,835 | — | |||||||||||||||
[6] Imputed interest on convertible debt, equity component amortization on convertible debt and others | — | — | — | 3,507 | — | |||||||||||||||
[7] Amortization of debt issuance costs | — | — | — | 920 | — | |||||||||||||||
[8] Amortization of acquisition-related intangible assets | 44,270 | — | 5,084 | — | — | |||||||||||||||
[9] Restructuring charges | — | 358 | 540 | — | — | |||||||||||||||
[10] Settlement charges | — | — | 3,500 | — | — | |||||||||||||||
[11] Tax impact of non-GAAP adjustments | — | — | — | 227 | 1,421 | |||||||||||||||
Non - GAAP [ii] | $ | 351,121 | $ | 77,994 | $ | 73,471 | $ | (13,337 | ) | $ | (3,083 | ) | ||||||||
Impact of reconciling items [ii - i] | $ | (49,910 | ) | $ | (10,601 | ) | $ | (21,787 | ) | $ | 7,905 | $ | 1,421 | |||||||
Table D: GAAP to non-GAAP reconciling items: Six Months Ended Q2 2018 | ||||||||||||||||||||
Cost of revenues | Research and development | SG&A and Restructuring costs | Interest and other expense, net | Income tax (provision) benefit | ||||||||||||||||
GAAP [i] | $ | 759,801 | $ | 189,926 | $ | 169,996 | $ | (39,513 | ) | $ | (10,211 | ) | ||||||||
[1] Stock-based compensation | 7,569 | 20,514 | 24,283 | — | — | |||||||||||||||
[2] Changes in value of deferred compensation plan | 163 | 739 | 922 | (1,389 | ) | — | ||||||||||||||
[3] Equity in net loss and impairment of equity method investees | — | — | — | 7,216 | — | |||||||||||||||
[4] Imputed interest on convertible debt, equity component amortization on convertible debt and others | — | — | — | 7,846 | — | |||||||||||||||
[5] Loss on extinguishment of Spansion convertible notes and debt issuance cost write off due to refinancing | — | — | — | 3,258 | — | |||||||||||||||
[6] Amortization of debt issuance costs | — | — | — | 1,073 | — | |||||||||||||||
[7] Amortization of acquisition-related intangible assets and other | 98,876 | — | 9,505 | — | — | |||||||||||||||
[8] Gain on sale of cost method investment | — | — | (1,521 | ) | — | — | ||||||||||||||
[9] Restructuring charges | 3,476 | 325 | 1,533 | — | — | |||||||||||||||
[10] Tax impact of non-GAAP adjustments | — | — | — | 16 | 4,072 | |||||||||||||||
Non - GAAP [ii] | $ | 649,717 | $ | 168,348 | $ | 135,274 | $ | (21,493 | ) | $ | (6,139 | ) | ||||||||
Impact of reconciling items [ii - i] | $ | (110,084 | ) | $ | (21,578 | ) | $ | (34,722 | ) | $ | 18,020 | $ | 4,072 | |||||||
Table E: GAAP to non-GAAP reconciling items: Six Months Ended Q2 2017 | ||||||||||||||||||||
Cost of revenues | Research and development | Selling, general and administrative | Interest and other expense, net | Income tax (provision) benefit | ||||||||||||||||
GAAP [i] | $ | 775,797 | $ | 177,943 | $ | 176,591 | $ | (45,677 | ) | $ | (9,431 | ) | ||||||||
[1] Stock-based compensation | 7,885 | 20,062 | 19,557 | — | — | |||||||||||||||
[2] Changes in value of deferred compensation plan | 304 | 1,160 | 1,904 | (3,142 | ) | — | ||||||||||||||
[3] Merger, integration, related costs and adjustments related to assets held for sale | 2,686 | (96 | ) | (286 | ) | — | — | |||||||||||||
[4] Inventory step-up related to acquisition accounting | 3,031 | — | — | — | — | |||||||||||||||
[5] Equity in net loss and impairment of equity method investees | — | — | — | 9,911 | — | |||||||||||||||
[6] Imputed interest on convertible debt, equity component amortization on convertible debt and others | — | — | — | 6,996 | — | |||||||||||||||
[7] Amortization of debt issuance costs | — | — | — | 1,778 | — | |||||||||||||||
[8] Amortization of acquisition-related intangible assets | 87,437 | — | 10,167 | — | — | |||||||||||||||
[9] Restructuring charges | 231 | 2,710 | 528 | — | — | |||||||||||||||
[10] Settlement charges | — | — | 3,500 | — | — | |||||||||||||||
[11] Tax impact of non-GAAP adjustments | — | — | — | 642 | 3,546 | |||||||||||||||
Non - GAAP [ii] | $ | 674,223 | $ | 154,107 | $ | 141,221 | $ | (29,492 | ) | $ | (5,885 | ) | ||||||||
Impact of reconciling items [ii - i] | $ | (101,574 | ) | $ | (23,836 | ) | $ | (35,370 | ) | $ | 16,185 | $ | 3,546 | |||||||
Table F: Non-GAAP gross profit | Three Months Ended | Six Months Ended | ||||||||||||||||||
Q2'18 | Q1'18 | Q2'17 | Q2'18 | Q2'17 | ||||||||||||||||
GAAP gross profit | $ | 234,138 | $ | 212,392 | $ | 192,745 | $ | 446,530 | $ | 349,853 | ||||||||||
Impact of reconciling items on cost of revenues (Table A, B, C, D and E) | (55,115 | ) | (54,970 | ) | (49,910 | ) | (110,084 | ) | (101,574 | ) | ||||||||||
Non-GAAP gross profit | $ | 289,253 | $ | 267,362 | $ | 242,655 | $ | 556,614 | $ | 451,427 | ||||||||||
GAAP gross margin (GAAP gross profit/revenue) | 37.5 | % | 36.5 | % | 32.5 | % | 37.0 | % | 31.1 | % | ||||||||||
Non-GAAP gross margin (Non-GAAP gross profit/revenue) | 46.3 | % | 45.9 | % | 40.9 | % | 46.1 | % | 40.1 | % | ||||||||||
Table G: Non-GAAP operating income | Three Months Ended | Six Months Ended | ||||||||||||||||||
Q2'18 | Q1'18 | Q2'17 | Q2'18 | Q2'17 | ||||||||||||||||
GAAP operating income (loss) [i] | $ | 50,846 | $ | 35,762 | $ | 8,892 | $ | 86,608 | $ | (4,681 | ) | |||||||||
Impact of reconciling items on cost of revenues (see Table A, B, C, D, E) | 55,115 | 54,970 | 49,910 | 110,084 | 101,574 | |||||||||||||||
Impact of reconciling items on R&D (see Table A, B, C, D, E) | 14,300 | 7,277 | 10,601 | 21,578 | 23,836 | |||||||||||||||
Impact of reconciling items on SG&A (see Table A, B, C, D, E) | 19,144 | 15,578 | 21,787 | 34,722 | 35,370 | |||||||||||||||
Non-GAAP operating income [ii] | $ | 139,405 | $ | 113,587 | $ | 91,190 | $ | 252,992 | $ | 156,099 | ||||||||||
Impact of reconciling items on operating income [ii - i] | $ | 88,559 | $ | 77,825 | $ | 82,298 | $ | 166,384 | $ | 160,780 | ||||||||||
GAAP operating margin (GAAP operating income / revenue) | 8.1 | % | 6.1 | % | 1.5 | % | 7.2 | % | (0.4 | )% | ||||||||||
Non-GAAP operating margin (Non-GAAP operating income / revenue) | 22.3 | % | 19.5 | % | 15.4 | % | 21.0 | % | 13.9 | % | ||||||||||
Table H: Non-GAAP pre-tax profit | Three Months Ended | Six Months Ended | ||||||||||||||||||
Q2'18 | Q1'18 | Q2'17 | Q2'18 | Q2'17 | ||||||||||||||||
GAAP income (loss) before income taxes and non-controlling interest ("Pre-tax income") | $ | 36,703 | $ | 17,608 | $ | (7,515 | ) | $ | 54,311 | $ | (40,447 | ) | ||||||||
Equity in net loss and impairment of equity method investees | (3,755 | ) | (3,461 | ) | (4,835 | ) | (7,216 | ) | (9,911 | ) | ||||||||||
Impact of reconciling items on operating income (see Table G) | 88,559 | 77,825 | 82,298 | 166,384 | 160,780 | |||||||||||||||
Impact of reconciling items on interest and other expense, net (see Table A, B, C, D, E) | 6,670 | 11,350 | 7,905 | 18,020 | 16,185 | |||||||||||||||
Non-GAAP pre-tax profit | $ | 128,177 | $ | 103,322 | $ | 77,853 | $ | 231,499 | $ | 126,607 | ||||||||||
GAAP pre-tax profit margin (GAAP pre-tax income/revenue) | 5.9 | % | 3.0 | % | (1.3 | )% | 4.5 | % | (3.6 | )% | ||||||||||
Non-GAAP pre-tax profit margin (Non-GAAP pre-tax profit/revenue) | 20.5 | % | 17.7 | % | 13.1 | % | 19.2 | % | 11.2 | % | ||||||||||
Table I: Non-GAAP net income (loss) | ||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||
Q2'18 | Q1'18 | Q2'17 | Q2'18 | Q2'17 | ||||||||||||||||
GAAP net income (loss) attributable to Cypress | $ | 27,706 | $ | 9,078 | $ | (16,920 | ) | $ | 36,784 | $ | (59,919 | ) | ||||||||
Impact of reconciling items on operating income (see Table G) | 88,559 | 77,825 | 82,298 | 166,384 | 160,780 | |||||||||||||||
Impact of reconciling items on interest and other expense, net (see Table A, B, C, D, E) | 6,670 | 11,350 | 7,905 | 18,020 | 16,185 | |||||||||||||||
Impact of reconciling items on income tax (provision) benefit (see Table A, B, C, D, E) | 2,029 | 2,043 | 1,421 | 4,072 | 3,546 | |||||||||||||||
Non-GAAP net income | $ | 124,964 | $ | 100,296 | $ | 74,704 | $ | 225,260 | $ | 120,592 | ||||||||||
Table J: Weighted-average shares, diluted | ||||||||||||||||||
Three Months Ended | ||||||||||||||||||
Q2'18 | Q1'18 | Q2'17 | ||||||||||||||||
GAAP | Non-GAAP | GAAP | Non-GAAP | GAAP | Non-GAAP | |||||||||||||
Weighted-average common shares outstanding, basic | 358,577 | 358,577 | 355,461 | 355,461 | 329,860 | 329,860 | ||||||||||||
Effect of dilutive securities: | ||||||||||||||||||
Stock options, unvested restricted stock and other | 7,837 | 14,391 | 7,897 | 12,515 | — | 15,822 | ||||||||||||
Convertible notes | 5,553 | 3,070 | 7,234 | 4,750 | — | 18,208 | ||||||||||||
Weighted-average common shares outstanding, diluted | 371,967 | 376,038 | 370,592 | 372,726 | 329,860 | 363,890 | ||||||||||||
Table K: Weighted-average shares, diluted | ||||||||||||
Six Months Ended | ||||||||||||
Q2'18 | Q2'17 | |||||||||||
GAAP | Non-GAAP | GAAP | Non-GAAP | |||||||||
Weighted-average common shares outstanding, basic | 356,123 | 356,123 | 328,320 | 328,320 | ||||||||
Effect of dilutive securities: | ||||||||||||
Stock options, unvested restricted stock and other | 7,879 | 13,071 | — | 15,466 | ||||||||
Convertible notes | 6,400 | 3,916 | — | 17,791 | ||||||||
Weighted-average common shares outstanding, diluted | 370,402 | 373,110 | 328,320 | 361,577 | ||||||||
Table L: Net income (loss) per share | ||||||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||||||
Q2'18 | Q1'18 | Q2'17 | ||||||||||||||||||||||
GAAP | Non-GAAP | GAAP | Non-GAAP | GAAP | Non-GAAP | |||||||||||||||||||
Net income (loss) (see Table I) [i] | $ | 27,706 | $ | 124,964 | $ | 9,078 | $ | 100,296 | $ | (16,920 | ) | $ | 74,704 | |||||||||||
Weighted-average common shares outstanding, diluted (see Table J) [ii] | 371,967 | 376,038 | 370,592 | 372,726 | 329,860 | 363,890 | ||||||||||||||||||
Earnings per share - diluted [i/ii] | $ | 0.07 | $ | 0.33 | $ | 0.02 | $ | 0.27 | $ | (0.05 | ) | $ | 0.21 | |||||||||||
Table M: Net income (loss) per share | ||||||||||||||||
Six Months Ended | ||||||||||||||||
Q2'18 | Q2'17 | |||||||||||||||
GAAP | Non-GAAP | GAAP | Non-GAAP | |||||||||||||
Net income (loss) (see Table I) [i] | $ | 36,784 | $ | 225,260 | $ | (59,919 | ) | $ | 120,592 | |||||||
Weighted-average common shares outstanding (see Table K) [ii] | 370,402 | 373,110 | 328,320 | 361,577 | ||||||||||||
Earnings per share - diluted [i/ii] | $ | 0.10 | $ | 0.60 | $ | (0.18 | ) | $ | 0.33 | |||||||
Table N: Adjusted EBITDA | ||||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||||
Q2'18 | Q1'18 | Q2'17 | Q2'18 | Q2'17 | ||||||||||||||||
GAAP net income (loss) attributable to Cypress | $ | 27,706 | $ | 9,078 | $ | (16,920 | ) | $ | 36,784 | $ | (59,919 | ) | ||||||||
Interest and other expense, net | (14,143 | ) | (18,154 | ) | (16,407 | ) | (32,297 | ) | (35,766 | ) | ||||||||||
Income tax provision | (5,154 | ) | (5,057 | ) | (4,504 | ) | (10,211 | ) | (9,431 | ) | ||||||||||
Equity in net loss of and impairment of equity method investees | (3,755 | ) | (3,461 | ) | (4,835 | ) | (7,216 | ) | (9,911 | ) | ||||||||||
Net gain (loss) attributable to non-controlling interests | (88 | ) | (12 | ) | (66 | ) | (100 | ) | (130 | ) | ||||||||||
GAAP operating income | $ | 50,846 | $ | 35,762 | $ | 8,892 | $ | 86,608 | $ | (4,681 | ) | |||||||||
Impact of reconciling items on operating income (see Table G) | 88,559 | 77,825 | 82,298 | 166,384 | 160,780 | |||||||||||||||
Non-GAAP operating income | $ | 139,405 | $ | 113,587 | $ | 91,190 | $ | 252,992 | $ | 156,099 | ||||||||||
Depreciation | 16,239 | 17,140 | 16,045 | 33,379 | 32,202 | |||||||||||||||
Adjusted EBITDA | $ | 155,644 | $ | 130,727 | $ | 107,235 | $ | 286,371 | $ | 188,301 | ||||||||||
CYPRESS SEMICONDUCTOR CORPORATION
SUPPLEMENTAL FINANCIAL DATA
(In thousands)
(Unaudited)
Three Months Ended | Six Months Ended | |||||||||||||||||||
July 1, 2018 | April 1, 2018 | July 2, 2017 | July 1, 2018 | July 2, 2017 | ||||||||||||||||
Selected Cash Flow Data (Preliminary): | ||||||||||||||||||||
Net cash provided by operating activities | $ | 110,734 | $ | 31,678 | $ | 32,447 | $ | 142,412 | $ | 58,168 | ||||||||||
Net cash (used in) provided by investing activities | $ | (7,213 | ) | $ | (14,173 | ) | $ | (14,992 | ) | $ | (21,386 | ) | $ | 6,658 | ||||||
Net cash used in financing activities | $ | (97,556 | ) | $ | (62,348 | ) | $ | (30,184 | ) | $ | (159,904 | ) | $ | (76,227 | ) | |||||
Other Supplemental Data (Preliminary): | ||||||||||||||||||||
Capital expenditures | $ | 25,593 | $ | 17,267 | $ | 15,577 | $ | 42,860 | $ | 29,349 | ||||||||||
Depreciation | $ | 16,239 | $ | 17,140 | $ | 16,045 | $ | 33,379 | $ | 32,202 | ||||||||||
Payment of dividend | $ | 39,404 | $ | 38,741 | $ | 36,217 | $ | 78,145 | $ | 71,754 | ||||||||||
Dividend paid per share | $ | 0.11 | $ | 0.11 | $ | 0.11 | $ | 0.22 | $ | 0.22 | ||||||||||
Total debt (principal amount) | $ | 955,553 | $ | 1,017,588 | $ | 1,280,390 | $ | 955,553 | $ | 1,280,390 | ||||||||||
Leverage ratio | 1.71 | 2.00 | 3.42 | 1.71 | 3.42 | |||||||||||||||
CYPRESS SEMICONDUCTOR CORPORATION
RECONCILIATION OF GAAP FORWARDING-LOOKING ESTIMATES TO NON-GAAP FORWARD-
LOOKING ESTIMATES
Forward-looking GAAP estimate (A) | Adjustments (B) | Forward-looking Non-GAAP estimate (C)=(A)+(B) | ||||||||||||||
Amortization of intangibles | Stock-based compensation expense | Other items | ||||||||||||||
Gross margin | 38.0% - 39.0% | 7.4 | % | 0.7 | % | 0.4 | % | 46.5% - 47.5% | ||||||||
Diluted earnings per share | $0.11 to $0.15 | $ | 0.14 | $ | 0.07 | $ | 0.04 | $0.36 to $0.40 | ||||||||
.
.